文献速递类风湿关节炎

类风湿关节炎临床发病前高危个体外周血中高度扩增T细胞克隆的检测

Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究对具有遗传风险的RA患者一级亲属(RA-FDR)在三个不同临床前阶段及匹配的RA患者(每组n=20)进行TCR CDR3β高通量测序,发现高度扩增克隆(HEC)在确诊RA患者中显著更高,在有症状RA-FDR中呈升高趋势,无症状RA-FDR中亦可检出,且纵向分析未发现与疾病发展密切相关的RA特异性克隆动力学扩增。

要点

  • 确诊RA患者HEC绝对数显著高于无症状RA-FDR(均值4.65 vs 1.55,P=0.003)。
  • 有症状RA-FDR的HEC绝对数较无症状RA-FDR呈升高趋势(均值3.4 vs 1.55,P=0.07)。
  • 无症状高水平ACPA个体与无症状RA-FDR的克隆数与频率无差异。

核心结论

  • RA临床发病前外周血中即可检出高度扩增T细胞克隆,尤其见于疾病发展的较晚临床前阶段,且其存在随时间增加。

研究设计与样本

  • 对RA-FDR按三个不同临床前阶段分组,并与匹配的RA患者每组n=20,行全血基因组DNA的TCR CDR3β高通量测序。

主要发现

  • 确诊RA患者HEC绝对数均值4.65,显著高于无症状RA-FDR的1.55(P=0.003)。
  • 有症状RA-FDR的HEC绝对数均值3.4,较无症状RA-FDR呈升高趋势(P=0.07)。
  • 无症状高ACPA个体与无症状RA-FDR在克隆绝对数和频率上无差异。
  • RA发病时HEC数量呈轻度升高趋势(P=0.055)。
  • 不同组内或组间未优先出现多患者共享克隆或既往与RA相关的克隆,纵向分析未发现与疾病发展密切相关的RA特异性克隆动力学扩增。

关键数值与推荐

  • 克隆频率超过0.5%定义为高度扩增克隆(HEC)。

临床怎么用

  • HEC检测或有助于识别RA临床前阶段的高危个体,尤其在有症状的RA-FDR中。
  • 无症状高ACPA个体未显示HEC差异,提示ACPA与T细胞克隆扩增在临床前阶段可能不完全同步。

局限性

  • 纵向分析未能揭示与疾病发展密切相关的RA特异性克隆动力学扩增。
  • 未发现多患者共享克隆或既往RA相关克隆在不同组间的优先分布。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To quantitatively profile the T-cell repertoire in the peripheral blood of individuals genetically at risk for RA, namely first-degree relatives of RA patients (RA-FDR) at different phases of disease development. METHODS: Next-generation sequencing of the TCR CDR3β repertoire was performed on genomic DNA isolated from whole blood samples of RA-FDR selected at three different pre-clinical stages and of matched RA patients (n = 20/group). T-cell clones were identified by their unique sequence and their degree of expansion (frequency) within each sample was characterized. Clones with a frequency over 0.5% were considered highly expanded clones (HEC). RESULTS: The absolute number of HEC was significantly higher in established RA patients (mean 4.65) and tended to be higher in symptomatic RA-FDR (mean 3.4) compared with asymptomatic RA-FDR (mean 1.55, P =0.003 and P =0.07, respectively). Asymptomatic individuals with high levels of ACPA did not differ from asymptomatic RA-FDR in terms of absolute number and frequency of clones. The number of HEC tended to be slightly higher at the time of RA onset (P =0.055). Neither clones shared by several patients, nor clones previously associated with RA, were preferentially present within or between the different groups. Finally, a longitudinal analysis did not allow to uncover a kinetic expansion of RA-specific clones closely correlated with disease development. CONCLUSIONS: HEC were detected in the peripheral blood before the clinical onset of RA, in particular in the later pre-clinical phase of RA development, and their presence increased over time.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lamacchia C, Calderin Sollet Z, Courvoisier D, et al. Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease. Rheumatology (Oxford). 2021. PMID: 33291148. doi:10.1093/rheumatology/keaa790

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。